Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).
Eleonora Teplinsky
No relevant relationships to disclose
Amanda Valeta
No relevant relationships to disclose
Rezina Arju
No relevant relationships to disclose
Shah Giashuddin
No relevant relationships to disclose
Yasmeen Sarfraz
No relevant relationships to disclose
Melissa Alexander
No relevant relationships to disclose
Farbod Darvishian
No relevant relationships to disclose
Deborah Silvera
No relevant relationships to disclose
Paul H. Levine
No relevant relationships to disclose
Salman Hashmi
No relevant relationships to disclose
Ladan Paul
No relevant relationships to disclose
Heather J. Hoffman
No relevant relationships to disclose
Baljit Singh
No relevant relationships to disclose
Judith D. Goldberg
No relevant relationships to disclose
Tsivia Hochman
No relevant relationships to disclose
Silvia Formenti
No relevant relationships to disclose
Robert Schneider
No relevant relationships to disclose
Komal L. Jhaveri
No relevant relationships to disclose